Objectives: This paper presents findings of a mandatory three-year evaluation of a prevention bonus scheme offered in the German Statutory Health Insurance (SHI). Its objective is to describe the rationale behind the programs, analyze their financial impact and discuss their implications on potentially conflicting goals on solidarity and competition.
Methods: The analysis included 70,429 insured enrolled in a prevention bonus program in a cohort study. The intervention group and their matched controls were followed for a three-year period. Matching was performed as nearest neighbor matching. The economic analysis comprised all costs relevant for Sickness Funds (SF) in the SHI and was carried out from a SHI perspective. Differences in cost trends between the intervention and the control group were examined applying the paired t-test.
Results: Regarding mean costs there was a significant difference between the two groups of euro177.48 (90% CI [euro149.73; euro205.24]) in favor of the intervention group. If program costs were considered cost reductions of euro100.88 (90% CI [euro73.12; euro128.63]) were obtained.
Conclusions: The uptake of a prevention bonus program led to cost reductions in the intervention group compared to the control group even when program costs were considered. However, the results must be interpreted with caution as in addition to financial aspects, socio-economic and health-status, selection bias and the function and use of bonus programs as marketing tools, as well as their long-term sustainability should be considered in future assessments.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.healthpol.2009.12.015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies.
Invest Ophthalmol Vis Sci
December 2024
4D Molecular Therapeutics, Emeryville, California, United States.
Purpose: Intravitreal delivery of therapeutic transgenes to the retina via engineered viral vectors can provide sustained local concentrations of therapeutic proteins and thus potentially reduce the treatment burden and improve long-term vision outcomes for patients with neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy.
Methods: We performed directed evolution in nonhuman primates (NHP) to invent an adeno-associated viral (AAV) variant (R100) with the capacity to cross vitreoretinal barriers and transduce all regions and layers of the retina following intravitreal injection. We then engineered 4D-150, an R100-based genetic medicine carrying 2 therapeutic transgenes: a codon-optimized sequence encoding aflibercept, a recombinant protein that inhibits VEGF-A, VEGF-B, and PlGF, and a microRNA sequence that inhibits expression of VEGF-C.
The Combined Use of High Pressure Processing and Lactic Acid Containing Fermentate on Inactivation of Salmonella, Shiga Toxin-producing E. coli, and Listeria monocytogenes in Raw Pet Foods.
J Food Prot
December 2024
TPS Consulting, LLC, 4 Big Bluff Ct, St. Charles, MO 63304, USA.
Raw meat pet foods can pose health risks to pets and humans. High-pressure processing (HPP) was used in a previous study to demonstrate its effectiveness in achieving a 5-log reduction of Salmonella, E. coli STEC, and L.
View Article and Find Full Text PDFHow Super Is Supertrack? Expediting Care of Fast-track Patients through a Pediatric Emergency Department.
Pediatr Qual Saf
September 2024
Section of Emergency Medicine, Stanford University School of Medicine, Department of Pediatrics, Palo Alto, Calif.
Background: Fast-track models decrease patient crowding in emergency departments (EDs) by redirecting low-acuity patients to an expedited care pathway. In 2016, this institution's pediatric ED created a fast-track pathway for patients evaluated in a rapid assessment triage area who needed further management in the primary ED. This "Supertrack" designation was intended for patients requiring up to 1 hour of additional care, though means of ensuring these patients were discharged within their anticipated timeframe were lacking.
View Article and Find Full Text PDFApplying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape.
Breast Cancer
November 2024
Department of Medical Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK.
Whole-genome sequencing (WGS) and whole-exome sequencing (WES) are crucial within the context of breast cancer (BC) research. They play a role in the detection of predisposed genes, risk stratification, and identification of rare single nucleotide polymorphisms (SNPs). These technologies aid in the discovery of associations between various syndromes and BC, understanding the tumour microenvironment (TME), and even identifying unknown mutations that could be useful in future for personalised treatments.
View Article and Find Full Text PDFHow adoption of new pharmaceuticals can impact US health system reimbursement under alternative payment models: An economic model measuring the impact of sotagliflozin among patients with heart failure and diabetes.
J Manag Care Spec Pharm
August 2024
Division of Cardiology, Department of Medicine, Stanford University, Palo Alto, CA.
Article Synopsis
- - Heart failure (HF) is a major cause of death, especially in patients with diabetes, leading to higher risks of death and readmission after hospitalization. The SOLOIST-WHF trial showed that sotagliflozin can lower readmission rates for these patients.
- - The study aimed to evaluate the 1-year financial effects of using sotagliflozin versus standard care for treating HF patients with diabetes in U.S. health systems, using a decision tree model to analyze clinical outcomes and economic implications.
- - Results indicated that a community hospital typically sees 83.4 HF patients with diabetes annually, and the use of sotagliflozin could significantly decrease hospitalizations, emergency department visits, and mortality rates by
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!